Show simple item record

FieldValueLanguage
dc.contributor.authorSitas Fen
dc.contributor.authorMalekzadeh Ren
dc.contributor.authorPawlita Men
dc.contributor.authorDawsey SMen
dc.contributor.authorWaterboer Ten
dc.contributor.authorWebb PMen
dc.contributor.authorGreen ACen
dc.contributor.authorHayward NKen
dc.contributor.authorZaridze Den
dc.contributor.authorHolcatova Ien
dc.contributor.authorMates Den
dc.contributor.authorEgger Sen
dc.contributor.authorSzeszenia-Dabrowska Nen
dc.contributor.authorFerro Gen
dc.contributor.authorJanout Ven
dc.contributor.authorCurado MPen
dc.contributor.authorMenezes AMen
dc.contributor.authorKoifman Sen
dc.contributor.authorIslami Fen
dc.contributor.authorNasrollahzadeh Den
dc.contributor.authorHu Nen
dc.contributor.authorGoldstein AMen
dc.contributor.authorUrban MIen
dc.contributor.authorGao Yen
dc.contributor.authorDing Ten
dc.contributor.authorKamangar Fen
dc.contributor.authorTaylor PRen
dc.contributor.authorAbnet CCen
dc.contributor.authorBoffetta Pen
dc.contributor.authorO'Connell DLen
dc.contributor.authorWhiteman DCen
dc.contributor.authorBrennan Pen
dc.date.issued2012
dc.identifier.urihttps://hdl.handle.net/2123/30296
dc.description.abstractBackground The role of human papillomavirus (HPV) in the causation of esophageal squamous cell carcinoma is unclear. We examined the associations between esophageal squamous cell carcinoma and 28 centrally measured HPV serological markers in serum from six existing case-control studies conducted in regions with differing background risks of esophageal cancer. Methods We used centralized multiplex serology to test serum samples from 1561 case subjects and 2502 control subjects from six case-control studies for antibodies to the major HPV capsid protein (L1) and/or the early proteins E6 and/or E7 of eight high-risk, two low-risk, and four cutaneous HPV types. Study-specific odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were estimated using conditional logistic regression with adjustment for smoking, alcohol consumption, and other potential confounders. Pooled odds ratios and 95% confidence intervals were calculated using either a linear mixed-effects approach or a joint fixed-effects approach. All statistical tests were two-sided. Results We found statistically significant associations between esophageal squamous cell carcinoma and antibodies to E6 for HPV16 (OR = 1.89, 95% CI = 1.09 to 3.29, P = .023) and HPV6 (OR = 2.53, 95% CI = 1.51 to 4.25, P < .001) but not for other tested HPV types. There were no statistically significant associations between esophageal squamous cell carcinoma and antibodies to E7 for any of the tested HPV types. Simultaneous seropositivity for HPV16 E6 and E7 was rare (four case subjects, two control subjects; OR = 5.57, 95% CI = 0.90 to 34.35; P = .064). We also found statistically significant associations between esophageal squamous cell carcinoma and capsid antibodies for the high-risk mucosal type HPV33 L1 (OR = 1.30, 95% CI = 1.00 to 1.69; P = .047) and the low-risk mucosal types HPV6 (OR = 1.22, 95% CI = 1.05 to 1.42; P = .010) and HPV11 (OR = 1.30, 95% CI = 1.09 to 1.56, P = .0036). Conclusions We found limited serological evidence of an association between esophageal squamous cell carcinoma and HPV in the populations studied. Although HPV does not appear to be an important risk factor for esophageal squamous cell carcinoma, we cannot exclude the possibility that certain HPV types may be involved in a small subset of cancersen
dc.publisherJournal of the National Cancer Instituteen
dc.rightsOther
dc.subjectAustraliaen
dc.subjectProteinsen
dc.subjectResearchen
dc.subjectRisken
dc.subjectSmokingen
dc.subjectcanceren
dc.subjectCase-Control Studiesen
dc.subjectConfidence Intervalsen
dc.subjectepidemiologyen
dc.subjectHPVen
dc.subjectmethodsen
dc.subjectOdds Ratioen
dc.subjectOtheren
dc.subject.otherCancer Type - Oesophageal Canceren
dc.subject.otherEtiology - Endogenous Factors in the Origin and Cause of Canceren
dc.titleInterSCOPE Study: Associations Between Esophageal Squamous Cell Carcinoma and Human Papillomavirus Serological Markersen
dc.typeArticleen
dc.identifier.doi10.1093/jnci/djr499
dc.relation.otherThe InterSCOPE collaboration was partially funded by the intramural research programs of the US National Cancer Institute; the German Cancer Research Center; and Cancer Council New South Wales, Australia; and by grants from the Deutsche Krebshilfe. Institutions who funded the field work of the original studies were Brazilian Multicentric Case–Control Study: European Commission (grant no IC18-CT97-0222); Central and Eastern European Case–Control Study: World Cancer Research Fund, European Commission (Contract No. IC15-CT98-0332); The Golestan Case–Control Study: Digestive Disease Research Center, Tehran University of Medical Sciences (Grant Number 82-603); The Australian Cancer Study: National Health and Medical Research Council (Program Grant No. 199600) (Australia); Johannesburg Cancer Case–Control Study: South African National Health Laboratory Service and Medical Research Council; University of the Witwatersrand; Cancer Research UK; Shanxi Case–Control Study: the US National Cancer Institute (Contract NO2-SC-66211).en
usyd.facultySeS faculties schools::Faculty of Medicine and Healthen


Show simple item record

Associated file/s

There are no files associated with this item.

Associated collections

Show simple item record

There are no previous versions of the item available.